Cost effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in the United Kingdom

 

Publication Type:
Presentation


Citation:

Meng Y, Hertel N, Ellis J, Johnson H, Philips Z, Roskell N and Lee D. Cost effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in the United Kingdom. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Vienna Austria. 29 October – 2 November 2016. Oral Presentation EE4.

 


Link to publication ⟶

⟵ Back to Search Results